The Efficacy of Velcade [bortezomib] on Bone Tissue During Myelomatosis (Bone Marrow Cancer).
Phase of Trial: Phase II
Latest Information Update: 07 Nov 2012
At a glance
- Drugs Bortezomib (Primary)
- Indications Multiple myeloma
- Focus Therapeutic Use
- 31 Aug 2018 Biomarkers information updated
- 14 Jul 2009 Status changed from active, no longer recruiting to completed as reported by ClinicalTrials.gov.
- 14 Jul 2009 Actual end date (Jul 2009) added as reported by ClinicalTrials.gov.